Merck, 1477604-4.59MG, Octreotide acetate

General description
Octreotide acetate is a synthetic cyclic octapeptide that mimics natural somatostatin, inhibiting the release of growth hormone, insulin, and glucagon. It is used therapeutically in acromegaly and neuroendocrine tumors. The USP reference standard enables identity, potency, and impurity testing in octreotide drug products.
The USP biologics peptides category encompasses a diverse range of therapeutic peptides that are essential in managing various medical conditions. These peptides, typically consisting of amino acid sequences of 40 residues or less, are critical for the development of high-quality medicines. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of peptide therapeutics throughout their lifecycle.
The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application
This USP reference standard is intended for use in specified quality tests and assays.
Also used to prepare standard and system suitability solutions in the assay of octreotide acetate as described in the United States Pharmacopeia (USP) monograph.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
This product is part of the USP Biologics program.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.